To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus
Clinical trial NCT03495765 · COMPLETED
Trial details
- NCT number
- NCT03495765
- Sponsor
- Marsden Eye Specialists
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-01
- Primary completion
- 2017-01-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.